A 2-Year Observational Study to Describe the Characteristics and Progression of Patients Suffering from Idiopathic Pulmonary Fibrosis Treated with Esbriet® in the Conditions of UseFirst published 27/05/2016 Last updated 14/03/2024 EU PAS number: EUPAS12456StudyFinalised
Astrid Scalori global.clinical_trial_registry@roche.comStudy contactglobal.clinical_trial_registry@roche.com